Press Releases

Date Title and Summary View
April 21, 2014 Eleven Biotherapeutics to Present at Upcoming Ophthalmology Industry Conferences View HTML
April 15, 2014 Eleven Biotherapeutics Announces Filing of its Annual Report on Form 10-K View HTML
April 1, 2014 Eleven Biotherapeutics Added to Russell Indexes on March 31, 2014 View HTML
March 20, 2014 Eleven Biotherapeutics to Present Data on Product Candidates at the ARVO 2014 Annual Meeting View HTML
March 4, 2014 Eleven Biotherapeutics Reports Clinical and Regulatory Updates for EBI-005 View HTML
March 3, 2014 Eleven Biotherapeutics Appoints Paul Chaney to Its Board of Directors View HTML
February 26, 2014 Eleven Biotherapeutics to Present at March Healthcare Conferences View HTML
February 18, 2014 Eleven Biotherapeutics Initiates Pivotal Phase 3 Clinical Study with EBI-005 in Dry Eye Disease View HTML
February 11, 2014 Eleven Biotherapeutics Closes Initial Public Offering View HTML
February 6, 2014 Eleven Biotherapeutics Prices Initial Public Offering View HTML